Sneha Pai, MD | |
201 Pennsylvania Pkwy Ste 315, Carmel, IN 46280-1393 | |
(317) 944-1000 | |
(317) 817-1410 |
Full Name | Sneha Pai |
---|---|
Gender | Female |
Speciality | Rheumatology |
Experience | 18 Years |
Location | 201 Pennsylvania Pkwy Ste 315, Carmel, Indiana |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1336484757 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RR0500X | Internal Medicine - Rheumatology | 01084104A (Indiana) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Indiana University Health | Indianapolis, IN | Hospital |
Indiana University Health North Hospital | Carmel, IN | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
University Medical Diagnostic Associates Inc | 3375446347 | 279 |
News Archive
According to new research which in many respects runs contrary to currently held beliefs it does not appear that children who watch a lot of television necessarily have behavior problems in school.
The Harvard Clinical Research Institute (HCRI) announced today that the DAPT Study has expanded into Australia and New Zealand. Professor Ian Meredith, MBBS, Ph.D., interventional cardiologist at MonashHeart in Melbourne, Australia and National Coordinating Investigator for the DAPT Study in Australia, was the first Pacific Rim investigator to enroll patients into the study.
A California Institute of Technology -led team of researchers and clinicians has published the first proof that a targeted nanoparticle-used as an experimental therapeutic and injected directly into a patient's bloodstream-can traffic into tumors, deliver double-stranded small interfering RNAs (siRNAs), and turn off an important cancer gene using a mechanism known as RNA interference (RNAi).
Cerevance, a clinical-stage drug discovery and development company focused on brain diseases, today announced the start of dosing in a Phase I first-in-human clinical trial of CVN424, an oral compound being developed for symptomatic treatment of Parkinson's disease.
› Verified 8 days ago
Entity Name | University Medical Diagnostic Associates Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1861441537 PECOS PAC ID: 3375446347 Enrollment ID: O20040202000510 |
News Archive
According to new research which in many respects runs contrary to currently held beliefs it does not appear that children who watch a lot of television necessarily have behavior problems in school.
The Harvard Clinical Research Institute (HCRI) announced today that the DAPT Study has expanded into Australia and New Zealand. Professor Ian Meredith, MBBS, Ph.D., interventional cardiologist at MonashHeart in Melbourne, Australia and National Coordinating Investigator for the DAPT Study in Australia, was the first Pacific Rim investigator to enroll patients into the study.
A California Institute of Technology -led team of researchers and clinicians has published the first proof that a targeted nanoparticle-used as an experimental therapeutic and injected directly into a patient's bloodstream-can traffic into tumors, deliver double-stranded small interfering RNAs (siRNAs), and turn off an important cancer gene using a mechanism known as RNA interference (RNAi).
Cerevance, a clinical-stage drug discovery and development company focused on brain diseases, today announced the start of dosing in a Phase I first-in-human clinical trial of CVN424, an oral compound being developed for symptomatic treatment of Parkinson's disease.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Sneha Pai, MD 250 N Shadeland Ave, Indianapolis, IN 46219-4959 Ph: () - | Sneha Pai, MD 201 Pennsylvania Pkwy Ste 315, Carmel, IN 46280-1393 Ph: (317) 944-1000 |
News Archive
According to new research which in many respects runs contrary to currently held beliefs it does not appear that children who watch a lot of television necessarily have behavior problems in school.
The Harvard Clinical Research Institute (HCRI) announced today that the DAPT Study has expanded into Australia and New Zealand. Professor Ian Meredith, MBBS, Ph.D., interventional cardiologist at MonashHeart in Melbourne, Australia and National Coordinating Investigator for the DAPT Study in Australia, was the first Pacific Rim investigator to enroll patients into the study.
A California Institute of Technology -led team of researchers and clinicians has published the first proof that a targeted nanoparticle-used as an experimental therapeutic and injected directly into a patient's bloodstream-can traffic into tumors, deliver double-stranded small interfering RNAs (siRNAs), and turn off an important cancer gene using a mechanism known as RNA interference (RNAi).
Cerevance, a clinical-stage drug discovery and development company focused on brain diseases, today announced the start of dosing in a Phase I first-in-human clinical trial of CVN424, an oral compound being developed for symptomatic treatment of Parkinson's disease.
› Verified 8 days ago
Dr. Shelagh Anne Fraser, MD Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 12174 N Meridian St Ste 300, Carmel, IN 46032 Phone: 317-688-9000 Fax: 317-680-9900 | |
Shania Grace Mayer, PA-C Rheumatology Medicare: Medicare Enrolled Practice Location: 10300 N Illinois St Ste 1100, Carmel, IN 46290 Phone: 317-944-0980 | |
Robert Mark Kinn, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 13806 Stone Dr, Carmel, IN 46032 Phone: 317-893-1900 | |
Olivia Ann Fondoble, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 13430 N Meridian St Ste 280, Carmel, IN 46032 Phone: 317-582-8030 | |
Dr. Peter Jerome Bustamante, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 13450 N Meridian St Ste 354, Carmel, IN 46032 Phone: 317-338-5100 | |
Thomas L Hutchinson, M.D. Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 11725 Illinois Street, Suite 465, Carmel, IN 46032 Phone: 317-817-0010 Fax: 317-817-0012 | |
Chintan J Amin, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 11725 Illinois St Ste 325, Carmel, IN 46032 Phone: 317-688-5800 Fax: 317-688-5805 |